Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BLCO NYSE:GKOS NYSE:STVN NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLCOBausch + Lomb$16.19-0.1%$16.22$10.99▼$18.92$5.77B0.59429,911 shs423,287 shsGKOSGlaukos$143.82+2.8%$118.35$73.16▼$148.11$8.45B0.94783,070 shs951,682 shsSTVNStevanato Group€17.76+2.5%€15.53€12.89▼€28.00€5.38B0.75649,617 shs379,076 shsWRBYWarby Parker$24.46-4.1%$23.71$14.96▼$31.00$2.62B1.953.20 million shs5.43 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLCOBausch + Lomb+0.64%+0.97%-3.70%-8.14%+37.77%GKOSGlaukos-1.67%+2.66%+12.55%+15.44%+46.23%STVNStevanato Group-1.76%-4.30%+12.34%+7.70%-29.04%WRBYWarby Parker-11.47%-5.88%+1.87%+11.54%+44.25%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLCOBausch + Lomb$16.19-0.1%$16.22$10.99▼$18.92$5.77B0.59429,911 shs423,287 shsGKOSGlaukos$143.82+2.8%$118.35$73.16▼$148.11$8.45B0.94783,070 shs951,682 shsSTVNStevanato Group€17.76+2.5%€15.53€12.89▼€28.00€5.38B0.75649,617 shs379,076 shsWRBYWarby Parker$24.46-4.1%$23.71$14.96▼$31.00$2.62B1.953.20 million shs5.43 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLCOBausch + Lomb+0.64%+0.97%-3.70%-8.14%+37.77%GKOSGlaukos-1.67%+2.66%+12.55%+15.44%+46.23%STVNStevanato Group-1.76%-4.30%+12.34%+7.70%-29.04%WRBYWarby Parker-11.47%-5.88%+1.87%+11.54%+44.25%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLCOBausch + Lomb 2.21Hold$18.0811.97% UpsideGKOSGlaukos 2.86Moderate Buy$144.42-0.61% DownsideSTVNStevanato Group 2.40HoldN/AN/AWRBYWarby Parker 2.63Moderate Buy$29.0019.89% UpsideCurrent Analyst Ratings BreakdownLatest WRBY, GKOS, BLCO, and STVN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2026WRBYWarby Parker Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight5/11/2026WRBYWarby Parker Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D) ➝ Hold (C-)5/8/2026WRBYWarby Parker UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$25.00 ➝ $27.005/8/2026WRBYWarby Parker Telsey Advisory GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$32.00 ➝ $33.005/7/2026WRBYWarby Parker BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$32.00 ➝ $34.004/30/2026BLCOBausch + Lomb Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$16.004/30/2026GKOSGlaukos Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$170.004/30/2026GKOSGlaukos CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$135.00 ➝ $140.004/30/2026GKOSGlaukos JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$120.00 ➝ $140.004/30/2026GKOSGlaukos Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$135.00 ➝ $138.004/30/2026GKOSGlaukos BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$131.00 ➝ $141.00(Data available from 5/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLCOBausch + Lomb$5.10B1.13$1.67 per share9.66$18.09 per share0.89GKOSGlaukos$507.44M16.82N/AN/A$11.42 per share12.72STVNStevanato Group€1.34B4.01€0.88 per share20.17€5.92 per share3.00WRBYWarby Parker$871.91M2.97$0.53 per share45.54$3.51 per share6.89Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLCOBausch + Lomb-$360M-$0.62N/A14.950.50-4.21%3.60%1.69%7/29/2026 (Estimated)GKOSGlaukos-$187.69M-$3.28N/A309.16N/A-34.34%-6.92%-5.25%7/29/2026 (Estimated)STVNStevanato Group€158.21M€0.5930.1522.231.6411.76%10.27%6.08%N/AWRBYWarby Parker$1.64M$0.021,210.7154.98N/A0.15%2.30%1.18%8/6/2026 (Estimated)Latest WRBY, GKOS, BLCO, and STVN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2026Q1 2026STVNStevanato Group€0.12€0.11-€0.01€0.10N/A€273.57 million5/7/2026Q1 2026WRBYWarby Parker$0.11$0.03-$0.08$0.03$239.44 million$242.45 million4/29/2026Q1 2026BLCOBausch + Lomb$0.06$0.08+$0.02-$0.20$1.22 billion$1.24 billion4/29/2026Q1 2026GKOSGlaukos-$0.30-$0.18+$0.12-$0.34$137.00 million$150.57 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBLCOBausch + LombN/AN/AN/AN/AN/AGKOSGlaukosN/AN/AN/AN/AN/ASTVNStevanato GroupN/AN/AN/AN/A1 YearsWRBYWarby ParkerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLCOBausch + Lomb0.781.530.99GKOSGlaukos0.105.434.73STVNStevanato Group0.211.631.11WRBYWarby ParkerN/A2.332.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLCOBausch + Lomb11.07%GKOSGlaukos99.04%STVNStevanato GroupN/AWRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipBLCOBausch + Lomb1.45%GKOSGlaukos5.90%STVNStevanato GroupN/AWRBYWarby Parker16.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLCOBausch + Lomb13,000356.57 million351.40 millionOptionableGKOSGlaukos1,09458.73 million55.27 millionOptionableSTVNStevanato Group6,010302.84 millionN/AOptionableWRBYWarby Parker4,036107.09 million89.10 millionOptionableWRBY, GKOS, BLCO, and STVN HeadlinesRecent News About These CompaniesWarby Parker Offers Glimpse of Google-Powered Smart Glasses2 hours ago | pymnts.comWarby Parker slides as investors compare its smart glasses to the Meta Ray-Ban lineMay 20 at 7:47 AM | msn.comWarby Parker Stock Slumps 11% as Questions Cloud Its Google Gemini AI Eyewear RevealMay 19 at 5:23 PM | barrons.comWarby Parker (NYSE:WRBY) Trading Down 6.6% - Here's WhyMay 19 at 3:52 PM | marketbeat.comGoogle and Samsung's Warby Parker and Gentle Monster Glasses Are Coming This FallMay 19 at 3:44 PM | cnet.comTimesSquare Capital Management LLC Boosts Stock Holdings in Warby Parker Inc. $WRBYMay 19 at 6:44 AM | marketbeat.comWarby Parker (NYSE:WRBY) Director Sells $574,961.17 in StockMay 18 at 4:43 AM | americanbankingnews.comUBS Remains a Hold on Warby Parker (WRBY)May 17 at 2:44 PM | theglobeandmail.comWarby Parker (NYSE:WRBY) Director Sells $140,205.33 in StockMay 16, 2026 | insidertrades.comWe Think Warby Parker's (NYSE:WRBY) Robust Earnings Are ConservativeMay 15, 2026 | finance.yahoo.comWarby Parker Sees Unusually High Options Volume (NYSE:WRBY)May 14, 2026 | marketbeat.comWarby Parker: Post-Earnings Strength Not Supported By Earnings (Rating Downgrade)May 13, 2026 | seekingalpha.comWarby Parker: Sales Slowdown And Margin DeleverageMay 13, 2026 | seekingalpha.comUBS Group AG Trims Stock Position in Warby Parker Inc. $WRBYMay 13, 2026 | marketbeat.comFirst Eagle Investment Management LLC Reduces Position in Warby Parker Inc. $WRBYMay 13, 2026 | marketbeat.comVanguard Group Inc. Sells 43,649 Shares of Warby Parker Inc. $WRBYMay 10, 2026 | marketbeat.comWarby Parker (NYSE:WRBY) Stock Price Expected to Rise, Telsey Advisory Group Analyst SaysMay 10, 2026 | americanbankingnews.comWarby Parker (NYSE:WRBY) Price Target Raised to $34.00May 10, 2026 | americanbankingnews.comComerica Bank Raises Holdings in Warby Parker Inc. $WRBYMay 10, 2026 | marketbeat.comA Look At Warby Parker’s Valuation As AI Glasses And Growth Outlook Support A Strong Share Price RunMay 9, 2026 | finance.yahoo.comWarby Parker Inc. 2026 Q1 - Results - Earnings Call PresentationMay 9, 2026 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeWRBY, GKOS, BLCO, and STVN Company DescriptionsBausch + Lomb NYSE:BLCO$16.18 -0.02 (-0.09%) Closing price 03:59 PM EasternExtended Trading$16.00 -0.18 (-1.14%) As of 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.Glaukos NYSE:GKOS$143.82 +3.92 (+2.80%) Closing price 03:59 PM EasternExtended Trading$143.76 -0.06 (-0.04%) As of 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.Stevanato Group NYSE:STVN€17.76 +0.43 (+2.49%) Closing price 03:59 PM EasternExtended Trading€17.77 +0.01 (+0.08%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.Warby Parker NYSE:WRBY$24.46 -1.05 (-4.11%) Closing price 03:59 PM EasternExtended Trading$24.36 -0.10 (-0.42%) As of 05:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook AI Consolidation Begins: Blackstone & Google Forge an AI Empire The Great AI Rotation: Cashing In on Data Mirum Pharma: A Rare Disease Growth Story to Watch Vertical Aerospace: Pre-Flight Checks Point to a Breakout HIVE Weaponizes Power for an AI Pivot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
